New Drugs: Sirolimus Topical Gel
FDA Approves Topical for Tuberous Sclerosis Complex By Ted Rosen, MD, FAAD Tuberous sclerosis complex (TSC) is an autosomal dominant genetic disorder that causes various types of tumors in a number of different tissues, including the skin. Some 50,000 individuals suffer from TSC in the United States. Aside from tumor growth, TSC has been […]